Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci

Immunology

Volumn 89, Issue 3, 1996, Pages 331-337

  Brandt, E R ^a   Hayman, W A ^a   Currie, B ^b   Carapetis, J ^b   Wood, Y ^c   Jackson, D C ^c   Cooper, J ^a   Melrose, W D ^d   Saul, A J ^f   Good, M F ^a,e  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d JAMES COOK UNIVERSITY   (Australia)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; M PROTEIN; SYNTHETIC PEPTIDE; VACCINE;

ABORIGINE; AFFINITY CHROMATOGRAPHY; ANTIBODY DETECTION; ARTICLE; AUSTRALIA; BACTERIAL INFECTION; CONTROLLED STUDY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; OPSONIZATION; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A;

EID: 10344223975     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-754.x     Document Type: Article

References (27)

1. WHO (1980) Community control of rheumatic heart disease in developing countries. (1): a major public health problem. WHO Chronicle 34, 336.
2. BRENNAN R.E. & PATEL M.S. (1990) Acute rheumatic fever and rheumatic heart disease in a rural central Australian Aboriginal Community. Med J Aust 153, 335.
3. CURRIE B. (1993) Medicine in tropical Australia. Med J Aust 153, 609.
4. JONES K.F., MANJULA B.N., JOHNSTON K.H., HOLLINGSHEAD S.K., SCOTT J.R. & FISCHETTI V.A. (1985) Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein. J Exp Med 161, 623.
5. DALE J.B., CHIANG E.Y. & LEDERER J.W. (1992) Recombinant Tetravalent Group A streptococcal M Protein Vaccine. J Immunol 151, 2188.
6. BEACHEY E.H., SEYER J.M. & DALE J.B. (1987) Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequence of types 5, 6 and 24 M proteins synthesised in tandem. J Exp Med 16, 647.
7. KEHOE M.A. (1991) New aspects of Streptococcus pyogenes pathogenicity. Rev Med Micro 2, 147.
8. BESSAN D. & FISCHETTI, V.A. (1988) Influence of intranasal immunisation with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonisation by group A streptococci. Infect Immun 56, 2666.
9. BESSAN D. & FISCHETTI V.A. (1990) Synthetic peptide vaccine against mucosal colonisation by group A streptococci. J Immunol 145, 1251.
10. FISCHETTI V.A., BESSAN D.E., SCHNEEWIND O. & HRUBY D.E. (1991) Protection against streptococcal pharyngeal colonisation with vaccines composed of M protein conserved regions. In: Immunobiol Prot Peptides (ed. M.Z. Atassi). p. 159. Plenum Press, New York.
11. BRONZE M.S., COURTNEY H.S. & DALE J.B. (1992) Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses. J Immunol 148, 888.
12. PRUKSAKORN S., GALBRAITH A., HOUGHTEN R.A. & GOOD M.F. (1992) Conserved T and B cell epitopes on the M protein of Group A Streptococci: Induction of bactericidal antibodies. J Immunol 149, 2729.
13. PRUKSAKORN S., CURRIE B., BRANDT E. et al. (1994) Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. Lancet 344, 639.
14. RELF W., COOPER J., BRANDT E. et al. (1996) Mapping a conserved epitope from the M protein of group A streptococci which is the target of opsonic human antibodies. Pep Research 9, 12.
15. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, of the American Heart Association. (1992) Guidelines for the diagnosis of rheumatic fever. JAMA 268, 2069.
16. HOUGHTEN R.A. (1985) General method for the rapid solid phase synthesis of large numbers of peptides: specificity of antigen antibody interaction at the level of individual amino acids. Proc Natl Acad Sci USA 82, 5231.
17. O'CONNER S.P., DARIP D., FRALEY K., NELSON C.M., KAPLAN E.L. & CLEARY P.P. (1991) The human antibody response to Streptococcal C5a peptidase. J Infect Dis 163, 109.
18. COLIGAN J.E., KRUISBEEK A.M., MARGULIE D.H., SHEVACH E.M. & STROBER W. (1992) Current Protocols in Immunology. Vol. 2, John Wiley, New York.
19. BUTZ S., RAWER S., RAPP W. & BIRSNER U. (1994) Immunization and affinity purification of antibodies using resin-immobilized lysine-branched synthetic peptides. Pep Research 7, 20.
20. LANCEFIELD R.C. (1957) Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J Exp Med 106, 525.
21. BEACHY E.H. & CUNNINGHAM M.W. (1973) Type-specific inhibitor of preopsonization versus immunoprecipitation by streptococcal M proteins. Infect Immun 8, 19.
22. BOACKLE R. (1993) The complement system. Immuno Ser 58, 135.
23. QUINN R.W., ZWAAG R.W. & LOWRY P.N. (1985) Acquisition of group A streptococcal M protein antibodies. Ped Infect Dis J 4, 374.
24. FISCHETTI V.A., BESSAN D.E., SCHNEEWIND O. & HRUBY D.E. (1991) Protection against streptococcal pharyngeal colonisation with vaccines composed of M protein conserved regions. In: Immunobiology of Proteins and Peptides VI (ed. M.Z. Atassi), p. 159. Plenum Press, New York.
25. KEMENY E., GRIEVE T., MARCUS R., SARELIS P. & ZABRISKIE J.B. (1989) Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin Immunol Immunopathol 52, 225.
26. PRUKSAKORN S., CURRIE B., BRANDT E. et al. (1994) Identification of T-cell autoepitopes that cross-react with the carboxylterminal segment of the M protein of group A streptococci. Int Immunol 6, 1235.
27. MILLER L.H., GOOD M.F. & MILON G. (1994) Disease pathogenesis in malaria. Science 264, 1878.